Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...
Q1 2026 Earnings Call February 2, 2026 9:00 AM ESTCompany ParticipantsJon Kathol - Vice President of Investor RelationsDonnie King ...
In a multicenter, phase 2 trial across 31 centers in 10 countries, apecotrep (BI 764198) reduced proteinuria by 40% over 12 ...
MedPage Today on MSN
Case Study: Strangely Elevated LDL Levels Persisting for Decades
Such a puzzle since the patient had neither CVD risk factors nor atherosclerotic changes ...
Pennsylvania Western failed to make the case, a judge ruled, that the requirement infringed on its right to set its own service standards and direct its work force.
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Takeda Pharmaceutical Company Limited ( TAK) Q3 2026 Earnings Call January 29, 2026 5:30 AM EST ...
ManpowerGroup Inc. (NYSE:MAN) Q4 2025 Earnings Call Transcript January 29, 2026 ManpowerGroup Inc. beats earnings ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
International Paper Company (NYSE:IP) Q4 2025 Earnings Call Transcript January 29, 2026 International Paper Company misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.28 ...
Montreal Gazette on MSN
Deadly falls are on the rise among older Quebecers. Prevention could save lives
Had she known the northwestern Quebec city of Val d’Or would be blanketed in snow in early November, Montrealer Anne Renaud would definitely not have worn her UGG boots, “which have absolutely no ...
While Bitcoin legitimizes the blockchain ecosystem, Coinbase profits by operating the dollar rails that institutions actually use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results